Inventor
ASHTON PAUL
US34 patents
⚠️ This page may combine multiple inventors who share the name “ASHTON PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PSIVIDA INC
10 patentsUS7279175B2Oct 9, 2007
Stent coated with a sustained-release drug delivery and method for use thereof
PSIVIDA INC125 citations97
US9603801B2Mar 28, 2017
Bioerodible silicon-based compositions for delivery of therapeutic agents
PSIVIDA INC10 citations82
US9962396B2May 8, 2018
Porous silicon drug-eluting particles
PSIVIDA INC2 citations73
US9808421B2Nov 7, 2017
Bioerodible silicon-based devices for delivery of therapeutic agents
PSIVIDA INC2 citations71
US9849085B2Dec 26, 2017
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
PSIVIDA INC1 citations63
US9192579B2Nov 24, 2015
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
PSIVIDA INC1 citations63
US9486459B2Nov 8, 2016
Porous silicon drug-eluting particles
PSIVIDA INC1 citations62
US10300114B2May 28, 2019
Bioerodible sustained release drug delivery systems
PSIVIDA INC0 citations51
US9566336B2Feb 14, 2017
In situ gelling drug delivery system
PSIVIDA INC1 citations51
US9980911B2May 29, 2018
Bioerodible silicon-based compositions for delivery of therapeutic agents
PSIVIDA INC1 citations50
UNIV KENTUCKY RES FOUND
7 patentsUS6001386ADec 14, 1999
Implantable controlled release device to deliver drugs directly to an internal portion of the body
UNIV KENTUCKY RES FOUND347 citations97
US5773019AJun 30, 1998
Implantable controlled release device to deliver drugs directly to an internal portion of the body
UNIV KENTUCKY RES FOUND599 citations97
US6051576AApr 18, 2000
Means to achieve sustained release of synergistic drugs by conjugation
UNIV KENTUCKY RES FOUND637 citations96
US5378475AJan 3, 1995
Sustained release drug delivery devices
UNIV KENTUCKY RES FOUND891 citations96
US5681964AOct 28, 1997
Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
UNIV KENTUCKY RES FOUND79 citations92
US6765019B1Jul 20, 2004
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
UNIV KENTUCKY RES FOUND16 citations91
US7214710B2May 8, 2007
Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
UNIV KENTUCKY RES FOUND0 citations51
ASHTON PAUL
4 patentsUS8252307B2Aug 28, 2012
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
ASHTON PAUL11 citations83
US9023896B2May 5, 2015
Porous silicon drug-eluting particles
ASHTON PAUL12 citations82
US11026885B2Jun 8, 2021
Bioerodible silicon-based devices for delivery of therapeutic agents
ASHTON PAUL3 citations71
US9333173B2May 10, 2016
Bioerodible silicon-based devices for delivery of therapeutic agents
ASHTON PAUL2 citations60
CONTROL DELIVERY SYS INC
3 patentsUS6375972B1Apr 23, 2002
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
CONTROL DELIVERY SYS INC541 citations98
US5902598AMay 11, 1999
Sustained release drug delivery devices
CONTROL DELIVERY SYS INC592 citations98
US6936270B2Aug 30, 2005
Device and method for treating conditions of a joint
CONTROL DELIVERY SYS INC94 citations97
GUO HONG
3 patentsUS8574659B2Nov 5, 2013
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
GUO HONG11 citations92
US8574613B2Nov 5, 2013
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
GUO HONG9 citations83
US8815284B2Aug 26, 2014
Bioerodible sustained release drug delivery systems
GUO HONG5 citations72
CONTROL DELIVERY SYSTEMS
2 patentsUS6548078B2Apr 15, 2003
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CONTROL DELIVERY SYSTEMS448 citations98
US6217895B1Apr 17, 2001
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CONTROL DELIVERY SYSTEMS546 citations98